​

iBio (IBIO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

IBIO Stock Forecast

iBio (IBIO) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $3.60, with a high of $3.60 and a low of $3.60. This represents a 318.60% increase from the last price of $0.86.

- $1 $2 $3 $4 $5 $6 High: $3.6 Avg: $3.6 Low: $3.6 Last Closed Price: $0.86

IBIO Stock Rating

iBio stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (75.00%), 1 Hold (25.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 1 3 Strong Sell Sell Hold Buy Strong Buy

IBIO Price Target Upside V Benchmarks

TypeNameUpside
StockiBio318.60%
SectorHealthcare Stocks 13.55%
IndustryBiotech Stocks 49.00%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.86$0.86$0.86
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 25-3---3
Aug, 25-3---3
Jul, 25-3---3
Jun, 25-3---3
May, 25-3---3
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 22, 2024Kemp DolliverLoop Capital Markets$3.60$2.2162.90%318.60%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 22, 2024Brookline CapitalBuyinitialise
May 28, 2024Chardan CapitalBuyinitialise
Oct 06, 2022Cantor FitzgeraldNeutralupgrade

Financial Forecast

EPS Forecast

$-250 $-200 $-150 $-100 $-50 $0 Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$-60.00$-58.49$-23.94$-6.50$-1.75----
Avg Forecast$-80.00$-105.00$-111.40$-7.41$-1.59$-1.38$-0.67$-0.74$-0.76
High Forecast$-80.00$-105.00$-53.47$-0.60$-0.76$-0.66$-0.32$-0.36$-0.36
Low Forecast$-80.00$-105.00$-227.26$-14.22$-3.24$-2.81$-1.37$-1.51$-1.55
Surprise %-25.00%-44.30%-78.51%-12.28%10.06%----

Revenue Forecast

$0 $9M $18M $27M $36M $45M Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$2.37M$1.88M-$225.00K$400.00K----
Avg Forecast$2.60M$2.55M$500.00K$25.00K$300.00K$800.00K$8.00M$24.00M$78.71K
High Forecast$2.60M$2.55M$900.01K$45.00K$540.00K$1.44M$14.40M$43.20M$141.67K
Low Forecast$2.60M$2.55M$300.00K$15.00K$180.00K$480.00K$4.80M$14.40M$47.22K
Surprise %-8.81%-26.12%-800.00%33.33%----

Net Income Forecast

$-900M $-720M $-540M $-360M $-180M $0 Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28 Jun 29
Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28Jun 29
Reported$-23.21M$-51.01M$-29.31M$-24.91M-----
Avg Forecast$-306.55M$-402.34M$-426.77M$-28.39M$-6.09M$-6.64M$-3.23M$-2.83M$-2.91M
High Forecast$-306.55M$-402.34M$-204.85M$-2.30M$-2.92M$-2.53M$-1.23M$-1.36M$-1.40M
Low Forecast$-306.55M$-402.34M$-870.63M$-54.47M$-12.43M$-10.75M$-5.24M$-5.78M$-5.94M
Surprise %-92.43%-87.32%-93.13%-12.26%-----

IBIO Forecast FAQ

Is iBio stock a buy?

iBio stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that iBio is a favorable investment for most analysts.

What is iBio's price target?

iBio's price target, set by 4 Wall Street analysts, averages $3.6 over the next 12 months. The price target range spans from $3.6 at the low end to $3.6 at the high end, suggesting a potential 318.60% change from the previous closing price of $0.86.

How does iBio stock forecast compare to its benchmarks?

iBio's stock forecast shows a 318.60% upside, outperforming the average forecast for the healthcare stocks sector (13.55%) and outperforming the biotech stocks industry (49.00%).

What is the breakdown of analyst ratings for iBio over the past three months?

  • September 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • August 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • July 2025: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is iBio’s EPS forecast?

iBio's average annual EPS forecast for its fiscal year ending in June 2026 is $-1.38, marking a -21.14% decrease from the reported $-1.75 in 2025. Estimates for the following years are $-0.67 in 2027, $-0.74 in 2028, and $-0.76 in 2029.

What is iBio’s revenue forecast?

iBio's average annual revenue forecast for its fiscal year ending in June 2026 is $800K, reflecting a 100.00% increase from the reported $400K in 2025. The forecast for 2027 is $8M, followed by $24M for 2028, and $78.71K for 2029.

What is iBio’s net income forecast?

iBio's net income forecast for the fiscal year ending in June 2026 stands at $-6.637M, representing a 0% decrease from the reported $0 in 2025. Projections indicate $-3.234M in 2027, $-2.835M in 2028, and $-2.912M in 2029.